The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer (Q84946928)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 November 2009

Language	Label	Description	Also known as
English	The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer	scientific article published on 20 November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

based on heuristic

inferred from title

Per-Uno Malmström

5

object named as

Per Malmström

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Marie Klintman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Pär-Ola Bendahl

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Dorthe Grabau

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Kristina Lövgren

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Mårten Fernö

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

South Sweden Breast Cancer Group

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

20 November 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Modern Pathology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

251-259

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19935641%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.167

0 references

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring proliferation in breast cancer: practicalities and applications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferation marker Ki-67 in early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki67 protein: the immaculate deception?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67, p53, ER receptors, ploidy and S phase as long-term prognostic factors in T1 node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading in breast cancer: interobserver agreement, and relation to other prognostic factors including ploidy.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.167

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84946928&oldid=1521572782"